NO920946D0 - Oral antikoagulant/blodplateinhibitor i lavdoseformulering - Google Patents

Oral antikoagulant/blodplateinhibitor i lavdoseformulering

Info

Publication number
NO920946D0
NO920946D0 NO920946A NO920946A NO920946D0 NO 920946 D0 NO920946 D0 NO 920946D0 NO 920946 A NO920946 A NO 920946A NO 920946 A NO920946 A NO 920946A NO 920946 D0 NO920946 D0 NO 920946D0
Authority
NO
Norway
Prior art keywords
oral anticoagulant
low dose
dose formulation
blood plate
inhibitor
Prior art date
Application number
NO920946A
Other languages
English (en)
Other versions
NO920946L (no
Inventor
William Joseph Addicks
Joseph A Mollica
Gary Howard Slatko
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of NO920946L publication Critical patent/NO920946L/no
Publication of NO920946D0 publication Critical patent/NO920946D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO920946A 1989-09-18 1992-03-11 Oral antikoagulant/blodplateinhibitor i lavdoseformulering NO920946D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation
PCT/US1990/004950 WO1991004031A1 (en) 1989-09-18 1990-09-05 Oral anticoagulant/platelet inhibitor low dose formulation

Publications (2)

Publication Number Publication Date
NO920946L NO920946L (no) 1992-03-11
NO920946D0 true NO920946D0 (no) 1992-03-11

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920946A NO920946D0 (no) 1989-09-18 1992-03-11 Oral antikoagulant/blodplateinhibitor i lavdoseformulering

Country Status (22)

Country Link
US (1) US5041430A (no)
EP (1) EP0493408B1 (no)
JP (1) JPH05501109A (no)
KR (1) KR950008307B1 (no)
AT (1) ATE137972T1 (no)
AU (1) AU635881B2 (no)
CA (1) CA2065347A1 (no)
CZ (1) CZ454090A3 (no)
DE (1) DE69027036D1 (no)
FI (1) FI921134A0 (no)
GR (1) GR1001131B (no)
HU (1) HUT62488A (no)
IE (1) IE903356A1 (no)
IL (1) IL95721A (no)
LV (1) LV10050B (no)
MA (1) MA21953A1 (no)
MX (1) MX173727B (no)
NO (1) NO920946D0 (no)
NZ (1) NZ235337A (no)
PT (1) PT95343B (no)
WO (1) WO1991004031A1 (no)
ZA (1) ZA907431B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
CA2218696A1 (en) * 1995-04-19 1996-10-24 L. Jackson Ii Roberts Compositions, kits and methods for administration of antilipemic and an ti-platelet aggregation drugs
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
AU2002226986A1 (en) * 2000-12-01 2002-06-11 Rheologics, Inc. In vivo delivery methods and compositions
WO2002079778A2 (en) * 2001-03-28 2002-10-10 Rheologics, Inc. In vivo delivery methods and compositions
US7691833B2 (en) * 2002-03-01 2010-04-06 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
EP1589930A2 (en) * 2003-01-08 2005-11-02 Flacco-Nesselroad Family Trust Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
EP1675651A1 (en) * 2003-10-20 2006-07-05 Teva Pharmaceutical Industries Limited Composition and dosage form for sustained effect of levodopa
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
JP2008500401A (ja) * 2004-05-21 2008-01-10 アキュ−ブレイク テクノロジーズ インコーポレーテッド 複数のセグメントを含む、刻み目のある医薬錠剤
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
US20100034878A1 (en) * 2006-12-19 2010-02-11 Bussey Henry I Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy
US20110041725A1 (en) * 2007-06-19 2011-02-24 Daniel Rittschof Anticoagulants as antifouling agents
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
CA2816957A1 (en) * 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ2012435A3 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (no) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
DE2860430D1 (en) * 1977-10-08 1981-02-26 Beecham Group Ltd Antithrombotic compositions containing benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
EP0169465B1 (de) * 1984-07-21 1990-02-28 Hoechst Aktiengesellschaft Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung

Also Published As

Publication number Publication date
GR900100702A (en) 1992-01-20
MX173727B (es) 1994-03-24
ZA907431B (en) 1992-05-27
IE903356A1 (en) 1991-04-10
GR1001131B (el) 1993-04-28
IL95721A (en) 1995-07-31
FI921134A (fi) 1992-03-17
JPH05501109A (ja) 1993-03-04
DE69027036D1 (de) 1996-06-20
CZ454090A3 (en) 1996-11-13
IL95721A0 (en) 1991-06-30
CA2065347A1 (en) 1991-03-19
AU6330690A (en) 1991-04-18
MA21953A1 (fr) 1991-04-01
FI921134A0 (fi) 1992-03-17
EP0493408A1 (en) 1992-07-08
KR920703046A (ko) 1992-12-17
AU635881B2 (en) 1993-04-01
NO920946L (no) 1992-03-11
PT95343B (pt) 1998-06-30
ATE137972T1 (de) 1996-06-15
US5041430A (en) 1991-08-20
EP0493408A4 (en) 1992-10-07
KR950008307B1 (ko) 1995-07-27
EP0493408B1 (en) 1996-05-15
NZ235337A (en) 1993-05-26
LV10050A (lv) 1994-05-10
WO1991004031A1 (en) 1991-04-04
PT95343A (pt) 1991-08-14
LV10050B (en) 1995-02-20
HUT62488A (en) 1993-05-28

Similar Documents

Publication Publication Date Title
NO920946L (no) Oral antikoagulant/blodplateinhibitor i lavdoseformulering
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
DE69008664T2 (de) Bestrahlung von bluterzeugnissen.
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
DE10199066I1 (de) Pharmazeutische Zusammensetzung
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
ES2054333T3 (es) Forma de dosificacion para administrar un antagonista del calcio.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
ATE6358T1 (de) 2-aminotetralin-verbindungen und pharmazeutische zusammensetzungen mit zentraler alpha1-agonist- wirksamkeit.
MX9202763A (es) Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene.
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
NO894158D0 (no) Curcumin ved paavisning av varsling av cyanid-oppblandete naeringsmidler.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
SE8802040D0 (sv) New use
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
DE69003003T2 (de) Pharmazeutische Zusammensetzung.
KR920700037A (ko) 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
ITMI932468A0 (it) Nuovi difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DE69006964T2 (de) Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen.
ATE72981T1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
IT8619001A0 (it) Alfa-alcossiimino-beta-lattami inibitori delle beta-lattamasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
MX9203372A (es) Composiciones farmaceuticas de buspirona y sales de la misma, de aplicacion oral.
SE8903901D0 (sv) Medicin artikel, y-platta